Cargando…
Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials
BACKGROUND: Shivering is a frequent complication after spinal anesthesia. Increasing studies have compared the effect of intravenous dexmedetomidine and intravenous tramadol on shivering after spinal anesthesia, hence we performed a meta-analysis of randomized controlled trials to compare dexmedetom...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199340/ https://www.ncbi.nlm.nih.gov/pubmed/32366218 http://dx.doi.org/10.1186/s12871-020-01020-y |
_version_ | 1783529138848530432 |
---|---|
author | Wang, Jinguo Wang, Zaitang Liu, Junyan Wang, Na |
author_facet | Wang, Jinguo Wang, Zaitang Liu, Junyan Wang, Na |
author_sort | Wang, Jinguo |
collection | PubMed |
description | BACKGROUND: Shivering is a frequent complication after spinal anesthesia. Increasing studies have compared the effect of intravenous dexmedetomidine and intravenous tramadol on shivering after spinal anesthesia, hence we performed a meta-analysis of randomized controlled trials to compare dexmedetomidine with tramadol on the treatment of post-spinal anesthesia shivering. METHODS: PubMed, Embase, Cochrane library, Web of Science and Google Scholar were searched to find the eligible studies comparing the effect of dexmedetomidine and tramadol on the treatment of shivering after spinal anesthesia. Mean difference (MD) or risk ratio (RR) along with 95% confidence interval (CI) was used to analyze the outcomes. I(2) test was conducted to assess the heterogeneity of the included trials. We utilized Review Manager 5.3 to perform statistical analyses. RESULTS: Thirteen randomized controlled trials including 864 subjects were included. Dexmedetomidine had higher effective rate of shivering control (RR =1.03; 95%CI [1.01, 1.06], P = 0.01, I(2) = 14%), shorter time to cease shivering (MD = -2.14; 95%CI [− 2.79, − 1.49], P < 0.00001, I(2) = 98%), lower recurrent rate of shivering (RR = 0.45; 95%CI [0.27, 0.73], P = 0.001, I(2) = 0%), lower incidences of nausea (RR = 0.10; 95%CI [0.05, 0.19], P < 0.00001, I(2) = 48%), and vomiting (RR = 0.13; 95%CI [0.06, 0.30], P < 0.00001, I(2) = 0%), higher incidence of sedation (RR = 2.48; 95%CI [1.32, 4.65], P = 0.005, I(2) = 82%), hypotension (RR = 2.50; 95%CI [1.24, 5.03], P = 0.01, I(2) = 0%) and bradycardia (RR = 4.78; 95%CI [1.76, 13.00], P = 0.002, I(2) = 0%), compared with tramadol. CONCLUSIONS: Dexmedetomidine is superior to tramadol for shivering treatment, due to higher effective rate of shivering control, earlier onset of action and lesser recurrence of shivering with higher incidence of sedation and lower incidences of nausea and vomiting. However, dexmedetomidine is also associated with higher incidences of hypotension and bradycardia than tramadol. |
format | Online Article Text |
id | pubmed-7199340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71993402020-05-08 Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials Wang, Jinguo Wang, Zaitang Liu, Junyan Wang, Na BMC Anesthesiol Research Article BACKGROUND: Shivering is a frequent complication after spinal anesthesia. Increasing studies have compared the effect of intravenous dexmedetomidine and intravenous tramadol on shivering after spinal anesthesia, hence we performed a meta-analysis of randomized controlled trials to compare dexmedetomidine with tramadol on the treatment of post-spinal anesthesia shivering. METHODS: PubMed, Embase, Cochrane library, Web of Science and Google Scholar were searched to find the eligible studies comparing the effect of dexmedetomidine and tramadol on the treatment of shivering after spinal anesthesia. Mean difference (MD) or risk ratio (RR) along with 95% confidence interval (CI) was used to analyze the outcomes. I(2) test was conducted to assess the heterogeneity of the included trials. We utilized Review Manager 5.3 to perform statistical analyses. RESULTS: Thirteen randomized controlled trials including 864 subjects were included. Dexmedetomidine had higher effective rate of shivering control (RR =1.03; 95%CI [1.01, 1.06], P = 0.01, I(2) = 14%), shorter time to cease shivering (MD = -2.14; 95%CI [− 2.79, − 1.49], P < 0.00001, I(2) = 98%), lower recurrent rate of shivering (RR = 0.45; 95%CI [0.27, 0.73], P = 0.001, I(2) = 0%), lower incidences of nausea (RR = 0.10; 95%CI [0.05, 0.19], P < 0.00001, I(2) = 48%), and vomiting (RR = 0.13; 95%CI [0.06, 0.30], P < 0.00001, I(2) = 0%), higher incidence of sedation (RR = 2.48; 95%CI [1.32, 4.65], P = 0.005, I(2) = 82%), hypotension (RR = 2.50; 95%CI [1.24, 5.03], P = 0.01, I(2) = 0%) and bradycardia (RR = 4.78; 95%CI [1.76, 13.00], P = 0.002, I(2) = 0%), compared with tramadol. CONCLUSIONS: Dexmedetomidine is superior to tramadol for shivering treatment, due to higher effective rate of shivering control, earlier onset of action and lesser recurrence of shivering with higher incidence of sedation and lower incidences of nausea and vomiting. However, dexmedetomidine is also associated with higher incidences of hypotension and bradycardia than tramadol. BioMed Central 2020-05-04 /pmc/articles/PMC7199340/ /pubmed/32366218 http://dx.doi.org/10.1186/s12871-020-01020-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Wang, Jinguo Wang, Zaitang Liu, Junyan Wang, Na Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title | Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title_full | Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title_fullStr | Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title_full_unstemmed | Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title_short | Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
title_sort | intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: a meta-analysis of randomized controlled trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199340/ https://www.ncbi.nlm.nih.gov/pubmed/32366218 http://dx.doi.org/10.1186/s12871-020-01020-y |
work_keys_str_mv | AT wangjinguo intravenousdexmedetomidineversustramadolfortreatmentofshiveringafterspinalanesthesiaametaanalysisofrandomizedcontrolledtrials AT wangzaitang intravenousdexmedetomidineversustramadolfortreatmentofshiveringafterspinalanesthesiaametaanalysisofrandomizedcontrolledtrials AT liujunyan intravenousdexmedetomidineversustramadolfortreatmentofshiveringafterspinalanesthesiaametaanalysisofrandomizedcontrolledtrials AT wangna intravenousdexmedetomidineversustramadolfortreatmentofshiveringafterspinalanesthesiaametaanalysisofrandomizedcontrolledtrials |